1608 Mitral Valve Disease Timing and Outcomes of Surgery

Abstract Aim Mitral valve disease (MVD) is a heart valvular defect associated with significant morbidity and mortality. Individual patient management depends on symptomatic disease, fitness type of pathology. Surgical intervention remains the standard for definitive management. The optimal time to operate debated considerations earlier surgical include reduced risk surgery co-morbidity prevention. We aim evaluate when patients MVD receive treatment if this outcome Method Patients who received between 2018 2020 were included. Electronic records examined, database was created demographics, symptoms, outcomes. Results Our cohort consisted n = 355, 198 receiving elective intervention. There higher male female ratio (58% vs 42% respectively). Mean 157.6 days mean age 71 years (24-93). Cohort mortality rate 6.5% (n 23). split into two groups; early (within 90 from diagnosis) consisting 59 late (after days) 139; demographics comorbidities similar in both groups. No associations found our variables. no association 60-day or any complication. Conclusions timing outcome. Early worse than later although data supports intervened at most appropriate according clinical evaluation.